Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |